Sign in to view content

New Tool for Predicting the 3-Year Risk of Vision-Threatening Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus

Bobeck S Modjtahedi, MD

Video
Published 2022

Related

Optical Coherence Tomographic Measures as Predictors of Functional Outcome For Diabetic Macular Edema Treated With Dexamethasone Implant
Matias Iglicki, MD
On Demand Cases, Courses, and Papers
2017
Amine Oxidase Copper-Containing 3 Inhibitor (BI 1467335) in Non-Proliferative Diabetic Retinopathy: Double-Masked, Randomized, Phase IIa Study (ROBIN)
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Annual Meeting Talks
2021
Board-Certified Providers Are Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections
Geoffrey G. Emerson, MD, PhD, FASRS
Annual Meeting Talks
2021

Category: Diabetic Retinopathy

See more